Captor Therapeutics Spolka Akcyjna (WSE:CTX)
Poland flag Poland · Delayed Price · Currency is PLN
78.00
-1.80 (-2.26%)
May 7, 2026, 9:56 AM CET

WSE:CTX Income Statement

Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4.6615.8313.29.163.99
Revenue Growth (YoY)
-70.55%19.88%44.15%129.75%-
Cost of Revenue
1.455.236.32.090.74
Gross Profit
3.2210.66.97.073.25
Selling, General & Admin
11.1411.4616.1424.0730.68
Research & Development
45.2943.970.8944.1623.12
Other Operating Expenses
-9.65-5.79-7.11-22.79-17.71
Operating Expenses
46.7849.5679.9245.4436.09
Operating Income
-43.56-38.97-73.02-38.36-32.84
Interest Expense
-0.28-0.39-0.27-0.32-0.4
Interest & Investment Income
-1.043.083.13-
Currency Exchange Gain (Loss)
--0.07-0.27-0.08-0.06
Other Non Operating Income (Expenses)
1.85-0.05-0.05-0.26-0.41
EBT Excluding Unusual Items
-42-38.43-70.53-35.89-33.7
Asset Writedown
----1.13
Pretax Income
-42-38.43-70.53-35.89-32.57
Income Tax Expense
--0.06--
Net Income
-42-38.43-70.58-35.89-32.57
Net Income to Common
-42-38.43-70.58-35.89-32.57
Shares Outstanding (Basic)
65544
Shares Outstanding (Diluted)
65544
Shares Change (YoY)
18.44%0.30%11.46%0.97%14.99%
EPS (Basic)
-7.61-8.25-15.19-8.61-7.89
EPS (Diluted)
-7.61-8.25-15.19-8.61-7.89
Free Cash Flow
-37.53-32.3-55.21-23.84-33.59
Free Cash Flow Per Share
-6.80-6.93-11.88-5.72-8.14
Gross Margin
68.99%66.95%52.28%77.21%81.41%
Operating Margin
-934.78%-246.24%-553.11%-418.91%-823.88%
Profit Margin
-901.22%-242.82%-534.69%-391.94%-817.16%
Free Cash Flow Margin
-805.36%-204.12%-418.22%-260.32%-842.60%
EBITDA
-39.19-33.91-67.58-31.27-25.49
EBITDA Margin
--214.27%---
D&A For EBITDA
4.375.065.447.097.36
EBIT
-43.56-38.97-73.02-38.36-32.84
EBIT Margin
--246.24%---
Source: S&P Global Market Intelligence. Standard template. Financial Sources.